The Pennsylvania Soybean Board is a farmer-directed organization responsible for administering Pennsylvania's share of the national soy checkoff. It invests checkoff dollars in research, education, and promotion to strengthen grower profitability; this hub highlights published research aimed at solving production problems, improving efficiency, and expanding opportunities for Pennsylvania soybean farmers.
Reports use the public sample. Complete portfolio reporting is available through a paid hub partnership.
Represent this organization? Explore a hub partnershipThe five questions a board asks
Each answer says what it is built from. Public records answer part of each question; the funder's own project list and reports complete it.
Evidence for the next decision
Read the result, understand its limits, and follow the evidence to its source.
Summaries from the research index
These takeaways are a starting point. They do not replace reviewed measurements, methods or institutional attribution.Indexed research summary
No soybean variety tested in Pennsylvania was immune to soybean vein necrosis virus, and the variety Channel3917R2x attracted the most thrips, making it the preferred host. Thrips feeding alone, and especially combined with virus infection, cut soybean growth and photosynthetic performance and altered seed protein, oil, fiber, and carbohydrate content.
Indexed research summary
Sequencing 72 avian reovirus isolates from Pennsylvania broiler flocks (2017-2022) found six genetically distinct genotype clusters circulating, with genotype V most common (33%) and amino acid identity to the commercial vaccine strains (1133, 1733, 2408, 2177) as low as 45%. Current vaccines are poorly matched to most field variants, so ongoing genotyping and autogenous/updated vaccine strategies are needed for reovirus control in broilers.
Indexed research summary
Of 301 avian reovirus isolates from Pennsylvania broiler and turkey flocks (2011–2014), 78% of the 114 sequenced strains fell into genotype clusters distinct from the S1133, 1733 and 2048 vaccine strains — including a brand-new cluster 6 — helping explain why vaccinated flocks still saw 20–40% morbidity, up to 10% mortality, arthritis/tenosynovitis and stunting. Existing commercial vaccines likely offer poor protection against these variants, so autogenous or updated vaccines should be considered.
The evidence query completed. Results may still await extraction or review. This is not evidence of no effect or proof that no research exists.
Commodity board · Managed hubs
Connect funded projects, publications and measured outcomes in a managed hub your board and producers can explore.
What happens next.
Your goals, who needs the evidence, and how you report today.
Built from public records under a private link, free, before any decision.
You decide what is worth maintaining. Fees follow the agreed scope.
Prefer email? Write to hello@open-ag-data.com. You hear back from Saurav Das, the founder, within two business days.
Ongoing curation, reporting and custom capabilities are part of a paid hub partnership, with scope and fees agreed before work begins.
This page is built from public records. With Pennsylvania Soybean Board's project list, amounts and final reports we map the whole history: who was funded, on what, where, what came of it, and what to fund next.
Indexed record counts are not counts of independent experiments or measured findings. Coverage reflects the records linked here, not all of the organization’s research.